Our Solutions

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double-blind, placebo-controlled trial

Synopsis
Dr. Beatrice Setnik, Chief Scientific Officer at Altasciences, contributes to the results and findings from a central nervous system (CNS) study.
URL
https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.13042
Date of publication
May 12, 2021
Category